Key result
Activity trackers in cardiac rehab reduce MACE ~49% and improve peak VO2 in CAD patients.
Why the study?
Activity trackers have been used in cardiac rehabilitation, but their effectiveness in influencing outcomes after coronary artery disease is debated.
Do activity trackers improve peak VO2, MACE, QoL, and LDL-C in patients with coronary artery disease?
Population
Patients with CAD across 11 randomized controlled trials
Comparison
Intervention groups with activity trackers vs control groups
Design
Systematic review and meta-analysis of randomized controlled trials
Authors
Loading...
Supports integrating activity trackers into cardiac rehabilitation for CAD patients; strengthens meta-analytic evidence for outcome improvement.
Meta-Analysis
Do activity trackers improve peak VO2, MACE, QoL, and LDL-C in patients with coronary artery disease?
Effect estimate: RR 0.51 (95% CI 0.31-0.86)
p-value: p=0.01
Cardiac rehabilitation using activity trackers improves peak VO2, reduces MACE, and enhances QoL in patients with coronary artery disease.
Kaihara et al. (2021) conducted a meta-analysis in coronary artery disease (CAD). activity trackers vs. control groups was evaluated on major adverse cardiovascular events (MACE) (RR 0.51, 95% CI 0.31-0.86, p=0.01). Activity trackers used in cardiac rehabilitation significantly decreased major adverse cardiovascular events (RR 0.51; 95% CI 0.31-0.86; P=0.01) and increased peak VO2 in patients with CAD.